医学
单克隆抗体病
不确定意义的单克隆抗体病
单克隆
免疫固定
单克隆抗体
回顾性队列研究
尿
血清蛋白电泳
病理
内科学
多发性骨髓瘤
胃肠病学
蛋白尿
华登氏巨球蛋白血症
作者
Merve Dincer,Özgür Aydın,Volkan Karakuş,Guzin Aykal
出处
期刊:Labmedicine
[Oxford University Press]
日期:2026-02-26
卷期号:57 (3)
标识
DOI:10.1093/labmed/lmag013
摘要
INTRODUCTION: Electrophoresis tests are reported as negative, positive, or-rarely-as suspicious for monoclonal band (SfMB). This study aimed to determine the fate of patients with SfMB findings in long-term follow-up. METHODS: Patients with SfMB results obtained in 2019 were retrospectively identified. These patients were examined for the presence of any control electrophoresis test until their most recent hospital visit in 2025. RESULTS: In 2019, electrophoresis tests were reported for a total of 1289 patients. In total, 115 patients with no prior electrophoresis test results were reported as positive (newly diagnosed patients) and 30 patients with no prior electrophoresis test results were reported as SfMB. Among the 30 SfMB cases, control electrophoresis tests had yielded a positive result in 2 patients and a negative result in 12 patients. In the remaining 16 patients, 7 were without control electrophoresis test results but had long clinical follow-up, whereas 9 were without a control electrophoresis test result and clinical follow-up. In 357 patients with a previously diagnosed monoclonal gammopathy, 18 were reported as SfMG. DISCUSSION: None of the patients initially reported as having an SfMB developed monoclonal gammopathy during their follow-up period. We recommend that cases reported as "suspicious" be managed separately in patients with and without a prior monoclonal gammopathy diagnosis, where the term "weak positive" may be more appropriate in patients with a known monoclonal gammopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI